Platinum-resistant recurrent ovarian cancer without germline BRCA1/2 mutation, 90% high-grade serous≥3 prior linesSomatic BRCA mutation status and mutation of HRR-related genes assessed. The gene discussed is BRCA1; the disease is ovarian cancer.